Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Low rate of intraperitoneal port placement in ovarian cancer patients, a population-based assessment.

Buckingham L, Koenig A, Ko EM, Brensinger CM, Latif N, Hummel C, Zhang X, Morgan MA, Burger RA, Giuntoli Ii RL.

Int J Gynecol Cancer. 2019 Jul 12. pii: ijgc-2019-000566. doi: 10.1136/ijgc-2019-000566. [Epub ahead of print]

PMID:
31302627
2.

Clopidogrel Drug Interactions and Serious Bleeding: Generating Real-World Evidence via Automated High-Throughput Pharmacoepidemiologic Screening.

Leonard CE, Zhou M, Brensinger CM, Bilker WB, Soprano SE, Pham Nguyen TP, Nam YH, Cohen JB, Hennessy S.

Clin Pharmacol Ther. 2019 May 20. doi: 10.1002/cpt.1507. [Epub ahead of print]

PMID:
31106397
3.

A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn's Disease Flares.

Albenberg L, Brensinger CM, Wu Q, Gilroy E, Kappelman MD, Sandler RS, Lewis JD.

Gastroenterology. 2019 Jul;157(1):128-136.e5. doi: 10.1053/j.gastro.2019.03.015. Epub 2019 Mar 11.

PMID:
30872105
4.

Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease.

Scott FI, Johnson FR, Bewtra M, Brensinger CM, Roy JA, Reed SD, Osterman MT, Mamtani R, Chen L, Yun H, Xie F, Curtis JR, Lewis JD.

Inflamm Bowel Dis. 2019 Apr 11;25(5):925-936. doi: 10.1093/ibd/izy321.

PMID:
30535149
5.

Correction: Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study.

Nam YH, Brensinger CM, Bilker WB, Leonard CE, Kasner SE, Grosser T, Li X, Hennessy S.

PLoS One. 2018 Jul 16;13(7):e0200982. doi: 10.1371/journal.pone.0200982. eCollection 2018.

6.

Serious Hypoglycemia and Use of Warfarin in Combination With Sulfonylureas or Metformin.

Nam YH, Brensinger CM, Bilker WB, Leonard CE, Han X, Hennessy S.

Clin Pharmacol Ther. 2019 Jan;105(1):210-218. doi: 10.1002/cpt.1146. Epub 2018 Aug 6.

PMID:
29885251
7.

Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study.

Nam YH, Brensinger CM, Bilker WB, Leonard CE, Kasner SE, Grosser T, Li X, Hennessy S.

PLoS One. 2018 Mar 14;13(3):e0193800. doi: 10.1371/journal.pone.0193800. eCollection 2018. Erratum in: PLoS One. 2018 Jul 16;13(7):e0200982.

8.

Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia.

Leonard CE, Brensinger CM, Aquilante CL, Bilker WB, Boudreau DM, Deo R, Flory JH, Gagne JJ, Mangaali MJ, Hennessy S.

Diabetes Care. 2018 Apr;41(4):713-722. doi: 10.2337/dc17-0294. Epub 2018 Feb 2.

9.

Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease.

Lewis JD, Scott FI, Brensinger CM, Roy JA, Osterman MT, Mamtani R, Bewtra M, Chen L, Yun H, Xie F, Curtis JR.

Am J Gastroenterol. 2018 Mar;113(3):405-417. doi: 10.1038/ajg.2017.479. Epub 2018 Jan 16.

10.

Thromboembolic and neurologic sequelae of discontinuation of an antihyperlipidemic drug during ongoing warfarin therapy.

Leonard CE, Brensinger CM, Bilker WB, Kimmel SE, Whitaker HJ, Hennessy S.

Sci Rep. 2017 Dec 21;7(1):18037. doi: 10.1038/s41598-017-18318-6.

11.

Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study.

Leonard CE, Han X, Brensinger CM, Bilker WB, Cardillo S, Flory JH, Hennessy S.

Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):9-18. doi: 10.1002/pds.4337. Epub 2017 Nov 6.

12.

The Authors Respond.

Leonard CE, Brensinger CM, Bilker WB, Chiang C, Li L, Hennessy S.

Epidemiology. 2018 Jan;29(1):e8-e9. doi: 10.1097/EDE.0000000000000759. No abstract available.

PMID:
28938236
13.

Increasing Incidence of Multiply Recurrent Clostridium difficile Infection in the United States: A Cohort Study.

Ma GK, Brensinger CM, Wu Q, Lewis JD.

Ann Intern Med. 2017 Aug 1;167(3):152-158. doi: 10.7326/M16-2733. Epub 2017 Jul 4.

PMID:
28672282
14.

Association Between Patient-Reported Medication Adherence and Anticoagulation Control.

Sevilla-Cazes J, Finkleman BS, Chen J, Brensinger CM, Epstein AE, Streiff MB, Kimmel SE.

Am J Med. 2017 Sep;130(9):1092-1098.e2. doi: 10.1016/j.amjmed.2017.03.038. Epub 2017 Apr 26.

15.

The quality of Medicaid and Medicare data obtained from CMS and its contractors: implications for pharmacoepidemiology.

Leonard CE, Brensinger CM, Nam YH, Bilker WB, Barosso GM, Mangaali MJ, Hennessy S.

BMC Health Serv Res. 2017 Apr 26;17(1):304. doi: 10.1186/s12913-017-2247-7.

16.

Biomedical Informatics Approaches to Identifying Drug-Drug Interactions: Application to Insulin Secretagogues.

Han X, Chiang C, Leonard CE, Bilker WB, Brensinger CM, Li L, Hennessy S.

Epidemiology. 2017 May;28(3):459-468. doi: 10.1097/EDE.0000000000000638.

17.

Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics.

Leonard CE, Brensinger CM, Bilker WB, Kimmel SE, Han X, Nam YH, Gagne JJ, Mangaali MJ, Hennessy S.

Int J Cardiol. 2017 Feb 1;228:761-770. doi: 10.1016/j.ijcard.2016.11.245. Epub 2016 Nov 12.

18.

A randomized trial of lottery-based incentives and reminders to improve warfarin adherence: the Warfarin Incentives (WIN2) Trial.

Kimmel SE, Troxel AB, French B, Loewenstein G, Doshi JA, Hecht TE, Laskin M, Brensinger CM, Meussner C, Volpp K.

Pharmacoepidemiol Drug Saf. 2016 Nov;25(11):1219-1227. doi: 10.1002/pds.4094. Epub 2016 Sep 4.

19.

Predicting prolonged dose titration in patients starting warfarin.

Finkelman BS, French B, Bershaw L, Brensinger CM, Streiff MB, Epstein AE, Kimmel SE.

Pharmacoepidemiol Drug Saf. 2016 Nov;25(11):1228-1235. doi: 10.1002/pds.4069. Epub 2016 Jul 26.

20.

Comparative risk of severe hypoglycemia among concomitant users of thiazolidinedione antidiabetic agents and antihyperlipidemics.

Leonard CE, Han X, Bilker WB, Flory JH, Brensinger CM, Flockhart DA, Gagne JJ, Cardillo S, Hennessy S.

Diabetes Res Clin Pract. 2016 May;115:60-7. doi: 10.1016/j.diabres.2016.03.006. Epub 2016 Mar 14.

21.

Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.

Mamtani R, Clark AS, Scott FI, Brensinger CM, Boursi B, Chen L, Xie F, Yun H, Osterman MT, Curtis JR, Lewis JD.

Arthritis Rheumatol. 2016 Oct;68(10):2403-11. doi: 10.1002/art.39738.

22.

Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics.

Leonard CE, Bilker WB, Brensinger CM, Han X, Flory JH, Flockhart DA, Gagne JJ, Cardillo S, Hennessy S.

Clin Pharmacol Ther. 2016 May;99(5):538-47. doi: 10.1002/cpt.297. Epub 2016 Jan 17.

23.

Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.

Scott FI, Mamtani R, Brensinger CM, Haynes K, Chiesa-Fuxench ZC, Zhang J, Chen L, Xie F, Yun H, Osterman MT, Beukelman T, Margolis DJ, Curtis JR, Lewis JD.

JAMA Dermatol. 2016 Feb;152(2):164-72. doi: 10.1001/jamadermatol.2015.3029.

24.

Pharmacoepidemiologic Methods for Studying the Health Effects of Drug-Drug Interactions.

Hennessy S, Leonard CE, Gagne JJ, Flory JH, Han X, Brensinger CM, Bilker WB.

Clin Pharmacol Ther. 2016 Jan;99(1):92-100. doi: 10.1002/cpt.277. Epub 2015 Nov 23. Review.

25.

Effectiveness and Safety of Immunomodulators With Anti-Tumor Necrosis Factor Therapy in Crohn's Disease.

Osterman MT, Haynes K, Delzell E, Zhang J, Bewtra M, Brensinger CM, Chen L, Xie F, Curtis JR, Lewis JD.

Clin Gastroenterol Hepatol. 2015 Jul;13(7):1293-1301.e5; quiz e70, e72. doi: 10.1016/j.cgh.2015.02.017. Epub 2015 Feb 24.

26.

Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.

Leonard CE, Bilker WB, Brensinger CM, Flockhart DA, Freeman CP, Kasner SE, Kimmel SE, Hennessy S.

Stroke. 2015 Mar;46(3):722-31. doi: 10.1161/STROKEAHA.114.006866. Epub 2015 Feb 5.

27.

Minimal benefit of earlier-than-recommended repeat colonoscopy among US Medicare enrollees following a negative colonoscopy.

Yang YX, French B, Localio AR, Brensinger CM, Lewis JD.

Aliment Pharmacol Ther. 2014 Oct;40(7):843-53. doi: 10.1111/apt.12902. Epub 2014 Aug 14.

28.

Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.

Kotlyar DS, Lewis JD, Beaugerie L, Tierney A, Brensinger CM, Gisbert JP, Loftus EV Jr, Peyrin-Biroulet L, Blonski WC, Van Domselaar M, Chaparro M, Sandilya S, Bewtra M, Beigel F, Biancone L, Lichtenstein GR.

Clin Gastroenterol Hepatol. 2015 May;13(5):847-58.e4; quiz e48-50. doi: 10.1016/j.cgh.2014.05.015. Epub 2014 May 28.

PMID:
24879926
29.

An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index.

Bewtra M, Brensinger CM, Tomov VT, Hoang TB, Sokach CE, Siegel CA, Lewis JD.

Inflamm Bowel Dis. 2014 Jun;20(6):1070-8. doi: 10.1097/MIB.0000000000000053.

30.

Facial emotion perception differs in young persons at genetic and clinical high-risk for psychosis.

Kohler CG, Richard JA, Brensinger CM, Borgmann-Winter KE, Conroy CG, Moberg PJ, Gur RC, Gur RE, Calkins ME.

Psychiatry Res. 2014 May 15;216(2):206-12. doi: 10.1016/j.psychres.2014.01.023. Epub 2014 Jan 23.

PMID:
24582775
31.

Development of abbreviated eight-item form of the Penn Verbal Reasoning Test.

Bilker WB, Wierzbicki MR, Brensinger CM, Gur RE, Gur RC.

Assessment. 2014 Dec;21(6):669-78. doi: 10.1177/1073191114524270. Epub 2014 Feb 26.

32.

Pharmacoepidemiologic and in vitro evaluation of potential drug-drug interactions of sulfonylureas with fibrates and statins.

Schelleman H, Han X, Brensinger CM, Quinney SK, Bilker WB, Flockhart DA, Li L, Hennessy S.

Br J Clin Pharmacol. 2014 Sep;78(3):639-48. doi: 10.1111/bcp.12353.

33.

Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial.

Kimmel SE, French B, Anderson JL, Gage BF, Johnson JA, Rosenberg YD, Geller NL, Kasner SE, Eby CS, Joo J, Caldwell MD, Goldhaber SZ, Hart RG, Cifelli D, Madigan R, Brensinger CM, Goldberg S, Califf RM, Ellenberg JH.

Am Heart J. 2013 Sep;166(3):435-41. doi: 10.1016/j.ahj.2013.04.009. Epub 2013 Jul 12. Erratum in: Am Heart J. 2014 Feb;167(2):281. Dosage error in article text.

34.

Randomized trial of lottery-based incentives to improve warfarin adherence.

Kimmel SE, Troxel AB, Loewenstein G, Brensinger CM, Jaskowiak J, Doshi JA, Laskin M, Volpp K.

Am Heart J. 2012 Aug;164(2):268-74. doi: 10.1016/j.ahj.2012.05.005.

35.

Development of abbreviated nine-item forms of the Raven's standard progressive matrices test.

Bilker WB, Hansen JA, Brensinger CM, Richard J, Gur RE, Gur RC.

Assessment. 2012 Sep;19(3):354-69. doi: 10.1177/1073191112446655. Epub 2012 May 17.

36.

The significance of the volume of pancreatic juice measured at secretin stimulation testing: a single-center evaluation of 224 classical secretin stimulation tests.

Lieb JG 2nd, Brensinger CM, Toskes PP.

Pancreas. 2012 Oct;41(7):1073-9. doi: 10.1097/MPA.0b013e318249a271.

PMID:
22481285
37.

More than just tapping: index finger-tapping measures procedural learning in schizophrenia.

Da Silva FN, Irani F, Richard J, Brensinger CM, Bilker WB, Gur RE, Gur RC.

Schizophr Res. 2012 May;137(1-3):234-40. doi: 10.1016/j.schres.2012.01.018. Epub 2012 Feb 16.

38.

Computerized neurocognitive test performance in schizophrenia: a lifespan analysis.

Irani F, Brensinger CM, Richard J, Calkins ME, Moberg PJ, Bilker W, Gur RE, Gur RC.

Am J Geriatr Psychiatry. 2012 Jan;20(1):41-52. doi: 10.1097/JGP.0b013e3182051a7d.

39.

Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity.

Lee I, Localio R, Brensinger CM, Blumberg EA, Lautenbach E, Gasink L, Amorosa VK, Lo Re V 3rd.

J Heart Lung Transplant. 2011 Nov;30(11):1266-74. doi: 10.1016/j.healun.2011.06.003. Epub 2011 Jul 20.

40.

Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure.

Testani JM, Cappola TP, Brensinger CM, Shannon RP, Kimmel SE.

J Am Coll Cardiol. 2011 Jul 19;58(4):375-82. doi: 10.1016/j.jacc.2011.01.052.

41.

Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study.

Schelleman H, Brensinger CM, Bilker WB, Hennessy S.

PLoS One. 2011;6(6):e21447. doi: 10.1371/journal.pone.0021447. Epub 2011 Jun 24. Erratum in: PLoS One. 2015;10(3):e0121926.

42.

Genetic warfarin dosing: tables versus algorithms.

Finkelman BS, Gage BF, Johnson JA, Brensinger CM, Kimmel SE.

J Am Coll Cardiol. 2011 Feb 1;57(5):612-8. doi: 10.1016/j.jacc.2010.08.643.

43.

Endoscopic Resection with Ligation Using a Multi-Band Mucosectomy System in Barrett's Esophagus with High-Grade Dysplasia and Intramucosal Carcinoma.

Bhat YM, Furth EE, Brensinger CM, Ginsberg GG.

Therap Adv Gastroenterol. 2009 Nov;2(6):323-30. doi: 10.1177/1756283X09346794.

44.

Exogenous estrogen does not attenuate the association between rofecoxib and myocardial infarction in perimenopausal women.

Wade KC, Ellenberg JH, Grosser T, Brensinger CM, Kimmel SE, Hennessy S.

J Cardiovasc Pharmacol. 2011 Feb;57(2):194-200. doi: 10.1097/FJC.0b013e31820350d3.

45.

New genetic variant that might improve warfarin dose prediction in African Americans.

Schelleman H, Brensinger CM, Chen J, Finkelman BS, Rieder MJ, Kimmel SE.

Br J Clin Pharmacol. 2010 Sep;70(3):393-9. doi: 10.1111/j.1365-2125.2010.03709.x.

46.

Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide.

Schelleman H, Bilker WB, Brensinger CM, Wan F, Hennessy S.

Clin Pharmacol Ther. 2010 Aug;88(2):214-22. doi: 10.1038/clpt.2010.74. Epub 2010 Jun 30.

47.

Multisensory integration of emotionally valenced olfactory-visual information in patients with schizophrenia and healthy controls.

Seubert J, Loughead J, Kellermann T, Boers F, Brensinger CM, Habel U.

J Psychiatry Neurosci. 2010 May;35(3):185-94.

48.

Psychiatric health care provider attitudes towards implantable medication.

Dankert ME, Brensinger CM, Ralph LN, Seward DA, Bilker WB, Siegel SJ.

Psychiatry Res. 2010 May 15;177(1-2):167-71. doi: 10.1016/j.psychres.2008.12.012. Epub 2010 Apr 7.

PMID:
20378184
49.

Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk.

Schelleman H, Bilker WB, Brensinger CM, Wan F, Yang YX, Hennessy S.

Am J Med. 2010 Feb;123(2):151-7. doi: 10.1016/j.amjmed.2009.07.020.

50.

Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study.

Platt AB, Localio AR, Brensinger CM, Cruess DG, Christie JD, Gross R, Parker CS, Price M, Metlay JP, Cohen A, Newcomb CW, Strom BL, Laskin MS, Kimmel SE.

Chest. 2010 Apr;137(4):883-9. doi: 10.1378/chest.09-0039. Epub 2009 Nov 10.

Supplemental Content

Loading ...
Support Center